Nanjing Well Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of pharmaceutical excipients and synthetic lubricating base oils. The Company's products mainly include mechanical synthetic lubricating base oils, non-mechanical synthetic lubricating base oils, injectable pharmaceutical excipients, and non-injectable pharmaceutical excipients. The Company distributes its products within the domestic market and to overseas markets.

Employees

718

Sector

Oil & Gas Refining and Marketing

More about the company

Quotes

Date	Price	Change	Volume
26-09-15	CN¥25.32	-0.55%	583,100
26-09-14	CN¥25.46	+0.75%	963,000
26-09-11	CN¥25.27	+0.28%	764,600
26-09-10	CN¥25.20	-1.18%	640,500
26-09-09	CN¥25.50	-1.51%	552,024

End-of-day quote Shanghai S.E.

More quotes

End-of-day quote Shanghai S.E. 2026-09-15			5-day change	1st Jan Change
25.32 ^CNY	-0.55%		-2.20%	-2.69%

08-21	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
06-15	Nanjing Well Pharmaceutical Group Co.,Ltd. signed a property rights transaction contract to acquire 50.98% stake in Lianyungang Wantai Pharmaceutical Excipients Technology Co., Ltd. from Tianjin Boguang Medical Biotechnology Development Co., Ltd. for CNY 19.4 million.	CI

Market Cap	3.43B 511M 442M 418M 379M 711M 48.99B 716M 4.99B 1.92B 24.84B 1.92B 1.88B 79.21B	P/E 2024	22.7x	P/E 2025	23.4x
Enterprise Value	3.58B 533M 462M 437M 395M 742M 51.14B 748M 5.21B 2B 25.93B 2B 1.96B 82.7B	EV / Sales 2024	2.75x	EV / Sales 2025	2.75x
Free-Float	38.51%	Yield 2024	1.63%	Yield 2025	2.31%

08-21	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
06-15	Nanjing Well Pharmaceutical Group Co.,Ltd. signed a property rights transaction contract to acquire 50.98% stake in Lianyungang Wantai Pharmaceutical Excipients Technology Co., Ltd. from Tianjin Boguang Medical Biotechnology Development Co., Ltd. for CNY 19.4 million.	CI
06-10	Nanjing Well Pharmaceutical Completes Updating Business Scope Registration	MT
04-27	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-27	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-26	Nanjing Well Pharmaceutical Group Co.,Ltd. announces Annual dividend, payable on June 05, 2026	CI
25-10-29	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-08-19	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-04-21	Nanjing Well Pharmaceutical Group Co.,Ltd. announces Annual dividend, payable on June 13, 2025	CI
25-04-21	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-21	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-10-23	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
24-08-19	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

1 day	-0.55%
1 week	-2.20%
Current month	-3.58%
1 month	-5.98%
3 months	+0.36%
6 months	-3.51%
Current year	-2.69%

Nanjing Well Pharmaceutical Group Co.,Ltd. Stock

Stocks

603351

CNE100003JD4

Oil & Gas Refining and Marketing

Valuation: Nanjing Well Pharmaceutical Group Co.,Ltd.

Chart: Nanjing Well Pharmaceutical Group Co.,Ltd.

Latest news: Nanjing Well Pharmaceutical Group Co.,Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: Nanjing Well Pharmaceutical Group Co.,Ltd.

Latest insider transactions

Other Oil & Gas Refining and Marketing

Financials

Company Profile

Quotes

1 week	24.75	25.8
1 month	24.75	28.09
Current year	21.9	28.9
1 year	21.9	30.8
3 years	17.65	33.34
5 years	17.65	42.62
10 years	17.08	42.62

Manager	Title	Age	Since
Ren Rong Wu CEO	Chief Executive Officer	63	2017-03-24
Qun Song Tang DFI	Director of Finance/CFO	59	2017-03-24
Zheng Song Gao CTO	Chief Tech/Sci/R&D Officer	61	2017-03-24

Director	Title	Age	Since
Ren Rong Wu CHM	Chairman	63	2017-03-24
Zheng Song Gao BRD	Director/Board Member	61	2017-03-24
Xin Guo Chen BRD	Director/Board Member	57	2017-03-24

	2024	2025
Net sales	1.3B 193M 167M 158M 143M 269M 18.52B 271M 1.89B 726M 9.39B 725M 709M 29.95B	1.34B 199M 172M 163M 147M 277M 19.07B 279M 1.94B 748M 9.67B 747M 730M 30.84B
Net income	146M 21.8M 18.89M 17.86M 16.17M 30.35M 2.09B 30.57M 213M 81.99M 1.06B 81.9M 80.09M 3.38B	151M 22.48M 19.47M 18.41M 16.67M 31.29M 2.16B 31.52M 220M 84.54M 1.09B 84.45M 82.57M 3.49B
Net Debt	234M 34.85M 30.19M 28.55M 25.84M 48.51M 3.34B 48.87M 341M 131M 1.7B 131M 128M 5.41B	151M 22.46M 19.45M 18.39M 16.65M 31.25M 2.15B 31.49M 220M 84.45M 1.09B 84.36M 82.49M 3.48B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NANJING WELL PHARMACEUTICAL GROUP CO.,LTD.	-0.55%	-2.20%	-10.88%	+0.68%	511M
EXXONMOBIL HOLDINGS CORPORATION	+2.57%	+5.39%	+50.71%	+45.09%	696B
RELIANCE INDUSTRIES LTD	+0.38%	-3.05%	-11.76%	+1.79%	174B
BP PLC	-0.49%	+3.68%	+36.94%	+11.25%	121B
MARATHON PETROLEUM CORPORATION	+3.63%	+3.29%	+128.32%	+167.11%	115B
VALERO ENERGY CORPORATION	+3.68%	+3.71%	+151.98%	+176.34%	114B
PHILLIPS 66	+3.06%	+2.23%	+101.96%	+118.90%	106B
CHINA PETROLEUM & CHEMICAL CORPORATION	-0.54%	-6.40%	+9.12%	+8.10%	90.45B
SUNCOR ENERGY INC.	+4.61%	+6.70%	+72.01%	+110.68%	84.03B
IMPERIAL OIL LIMITED	+2.77%	+4.09%	+47.10%	+135.21%	65.41B
Average	+0.78%	+1.71%	+57.55%	+77.51%	156.72B
Weighted average by Cap.	+0.15%	+2.30%	+57.83%	+66.33%